BioXpress And Abzena Partner On Biosimilar Development
Alliance Will Aid Development And Manufacturing Of Biosimilars For Global Customers
BioXpress Therapeutics and Abzena, two service providers with expertise in biosimilar development, have partnered to support biosimilar development for third party customers. The companies plan to offer a “flexible and innovative approach from small scale biosimilar development through to large scale manufacturing.”
